PRESS RELEASE published on 08/28/2025 at 06:59, 1 year 2 months ago Biophytis Receives EMA and Belgian Regulatory Approval to Initiate Phase 3 Sarcopenia Clinical Trial Biophytis receives EMA and Belgian regulatory approval for Phase 3 sarcopenia clinical trial, enabling patient enrolment in Belgium and collaboration with European centers Biophytis Sarcopenia Phase 3 EMA Approval Belgian Regulatory Approval
BRIEF published on 08/05/2025 at 23:05, 1 year 3 months ago Biophytis Secures €1 Million Non-Dilutive Bond Financing Biophytis Bond Financing Shareholder Impact Non-dilutive OBA101 Program
REGULATED PRESS RELEASE published on 08/05/2025 at 23:00, 1 year 3 months ago Biophytis Secures Non-Dilutive Bond Financing Line of up to €1 Million Biophytis secures a non-dilutive bond financing line of up to €1 million with Hexagon Capital Fund to support OBA101 program development and strengthen cash position Biophytis Financing Hexagon Capital Fund OBA101 Program Non-dilutive Bond
PRESS RELEASE published on 08/05/2025 at 22:59, 1 year 3 months ago Biophytis Secures Non-Dilutive Bond Financing Line of up to €1 Million Biophytis secures a non-dilutive bond financing line of up to €1 million from Hexagon Capital Fund. The bonds, with 12% annual interest rate, will mature in 24 months and may be repaid in shares Biophytis Hexagon Capital Fund Non-dilutive Bond Financing 12% Interest Rate Repayment In Shares
BRIEF published on 07/30/2025 at 07:05, 1 year 3 months ago Biophytis Joins Silver Innov' to Boost Silver Economy Initiatives Biophytis Healthcare Innovation Longevity Sarcopenia Silver Innov'
REGULATED PRESS RELEASE published on 07/30/2025 at 07:00, 1 year 3 months ago Biophytis Joins Silver Innov', an Incubator Dedicated to the Silver Economy Biophytis relocates to Silver Innov' in Paris, embracing the silver economy ecosystem for innovation and healthcare in aging, strengthening academic and clinical research collaborations Innovation Biophytis Healthcare Silver Innov Aging
BRIEF published on 07/16/2025 at 07:05, 1 year 3 months ago Biophytis Achieves Legal Victory in Court of Cassation Biophytis Legal Victory Court Of Cassation Negma Group Convertible Bond Dispute
REGULATED PRESS RELEASE published on 07/16/2025 at 07:00, 1 year 3 months ago Biophytis Wins Major Legal Victory Before the French Court of Cassation Biophytis celebrates a major legal win at the French Court of Cassation validating its position in the dispute with Negma Group, a landmark decision protecting the company's interests Biophytis Legal Victory Court Of Cassation Negma Group Landmark Ruling
PRESS RELEASE published on 07/16/2025 at 06:59, 1 year 3 months ago Biophytis Wins Major Legal Victory Before the French Court of Cassation Biophytis celebrates major legal win as French Court of Cassation rules in its favor against Negma Group, marking a turning point in the litigation and validating the company's legal position Biophytis Litigation Legal Victory Negma Group French Court Of Cassation
BRIEF published on 07/15/2025 at 07:05, 1 year 3 months ago Biophytis Partners with Lynx Analytics for AI-Driven Drug Discovery Biophytis Drug Discovery Sarcopenia AI Partnership Lynx Analytics
Published on 11/05/2026 at 22:05, 1 hour 12 minutes ago Innodata Reports Record Third Quarter 2026 Results
Published on 11/05/2026 at 22:01, 1 hour 16 minutes ago Unusual Machines Third Quarter 2026 Shareholder Letter
Published on 11/05/2026 at 15:20, 7 hours 57 minutes ago MicroVision and LAKE FUSION Technologies Sign Multi-Year Strategic Partnership Agreement for IRIS(TM) Lidar Sensors
Published on 11/05/2026 at 14:31, 8 hours 46 minutes ago First Breach Close-Quarters Strike (CQS) Drone Successfully Completes Full Mission Profile
Published on 11/05/2026 at 14:25, 8 hours 52 minutes ago Polaris Renewable Energy Announces Q3 2026 Results
Published on 11/05/2026 at 22:05, 1 hour 12 minutes ago Quantinuum Reports Third Quarter 2026 Results and Raises Full-Year Revenue Outlook
Published on 11/05/2026 at 20:38, 2 hours 38 minutes ago freenet uses funds from Ceconomy sale for waipu.tv acquisition and share buyback
Published on 11/05/2026 at 20:37, 2 hours 40 minutes ago EQS-Adhoc: freenet AG decides on share buyback programme for up to EUR 75 million
Published on 11/05/2026 at 19:45, 3 hours 31 minutes ago Stabilus SE fulfills forecast for fiscal 2026 and adjusts 2030 medium-term targets
Published on 11/05/2026 at 19:41, 3 hours 36 minutes ago EQS-Adhoc: Stabilus SE – Around €67 million in non-cash impairments reduce EBIT for FY2026; Preliminary Q4 FY2026 figures: Revenue and adjusted EBIT exceed market expectations, while adjusted free cash flow fall
Published on 11/05/2026 at 18:21, 4 hours 55 minutes ago Total number of voting rights and shares making up the share capital at October 31, 2026
Published on 11/05/2026 at 17:45, 5 hours 32 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 11/05/2026 at 17:29, 5 hours 47 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN FR0010406082
Published on 11/05/2026 at 10:16, 13 hours ago Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%
